Home / Levodopa and Decarboxylase Inhibitor / Czechia
CZ ATC N04BA02 · updated 2 Nov 2026
Levodopa and Decarboxylase Inhibitor shortage in Czechia
Is there a Levodopa and Decarboxylase Inhibitor shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Levodopa and Decarboxylase Inhibitor product is reported short in Czechia, the first since 2 Sep 2026. The company estimate for the return is 20 Nov 2026. Main reason: distribution or logistics.
Also short in Canada, Norway, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | NAKOM 250MG/25MG 250MG/25MG TBL NOB 100 | Lek Pharmaceuticals d.d., Ljubljana | 2 Sep 2026 | 20 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.